Industry: France
Cardiovascular Outcomes# LEADER Trial (Liraglutide)# The LEADER trial (Marso et al., NEJM 2016) enrolled 9,340 patients with type 2 diabetes and high cardiovascular risk
Subcutaneous injections are administered into the fatty tissue just beneath the skin, most commonly in the abdomen, upper thigh, or upper arm
Concurrently, the nanoreactors also activate the systemic immune system in mice, preventing tumor metastasis and recurrence
If you or a loved one has developed NAION while using Ozempic or another GLP-1 drug, you may be entitled to compensation
Another study demonstrated that oral exposure to high doses of Mn during the first 20 days of postnatal life reduces dopamine release later in young adolescent rats (Song et al., 2016